Compounds > opc 12759
Page last updated: 2024-08-16

opc 12759 and chitosan

opc 12759 has been researched along with chitosan in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Akira, Y; Duan, L; Huang, BB; Li, GF; Luo, JH; Nobuaki, K1
Kamiki, Y; Makino, K; Takeuchi, I1
Makino, K; Takeuchi, I; Togo, C1
Cui, X; Deng, Z; Han, B; Jiang, C; Jing, Y; Li, W; Shi, F; Sun, M; Xia, S; Xu, Z; Zhang, W; Zhou, Z1

Other Studies

4 other study(ies) available for opc 12759 and chitosan

ArticleYear
Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier.
    World journal of gastroenterology, 2008, Aug-21, Volume: 14, Issue:31

    Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Capsules; Chemistry, Pharmaceutical; Chitosan; Colon; Diffusion; Drug Carriers; Gelatin; Glycerides; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Lauric Acids; Male; Organic Chemicals; Permeability; Quinolones; Rats; Rats, Wistar; Solubility

2008
Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy.
    Colloids and surfaces. B, Biointerfaces, 2018, Jul-01, Volume: 167

    Topics: Alanine; Animals; Anti-Ulcer Agents; Chitosan; Coated Materials, Biocompatible; Drug Liberation; Fluorouracil; Lactic Acid; Male; Mice, Inbred ICR; Microscopy, Electron, Scanning; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Quinolones; Stomatitis; Treatment Outcome

2018
Rebamipide-containing Film Using Chitosan and HPMC for Oral Mucositis Induced by Cancer Chemotherapy.
    Anticancer research, 2019, Volume: 39, Issue:12

    Topics: Alanine; Antineoplastic Agents; Chitosan; Delayed-Action Preparations; Humans; Hypromellose Derivatives; Quinolones; Stomatitis

2019
Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway.
    Biomaterials science, 2020, Feb-07, Volume: 8, Issue:3

    Topics: Alanine; Animals; Cell Proliferation; Chitosan; Dogs; Drug Compounding; Humans; Macrophages; Male; Nanoparticles; NF-kappa B; Prostate; Prostatic Hyperplasia; Quinolones; Wound Healing

2020